Understanding how in vitro macrophage assays drive IO development forward [WEBINAR]

Sign in to Miltenyi University to view the slides from the video and explore more learning opportunities. https://www.miltenyibiotec.com/resour... For more information, visit: https://www.miltenyibiotec.com/produc... TAMs and the TME: Learn how pre-clinical in vitro techniques help predict the effect of immunotherapeutics in vivo. Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies cover techniques of sample preparation, cell isolation, cell sorting, flow cytometry, cell culture, molecular analysis, and preclinical imaging. Our 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has 3,000 employees in 28 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.